PATENT CLAIM ANALYSIS

Application Number: 15897099
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "061000"]

Abstract:
The application relates to a method for treating a patient with irritable bowel syndrome (IBS), the method comprising administering to the patient a mixture comprising 2′-fucosyllactose (2′-FL) and lacto-N-neotetraose (LNnT).

Claim (Index 3):
The method of  claim 1 , wherein the symptom is chronic and selected from one or more of the following: abdominal pain, abdominal discomfort, abdominal bloating, change in bowel movement patterns, diarrhea and constipation.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 88.0
- Lexical Diversity: 1.40741
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15555936', '13397556', '16071696', '15579818', '15753692']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7681520831876809
- 35 USC 102 Novelty (BERT): 0.512067285860609
- Combined Prediction Score: 0.7425436034549737
- Mean Citation Score: 212.34407
- Max Citation Score: 234.7496
- Similarity Product: 139.04197768259047

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test